Scientific Glossary

▾

Titration protocols start below the target study quantity and increase incrementally over weeks. GLP-1 agonist trials use structured titration (e.g., semaglutide: 0.25mg/week x4 → 0.5mg/week x4 → 1mg/week x4 → 2.4mg final maintenance). This approach reduces the incidence of GI side effects by allowing adaptation. The trade-off is delayed onset of full effect. Titration schedules in research literature vary by compound — BPC-157 and TB-500 protocols typically don't require titration given their short half-lives and absence of receptor desensitization concerns.